Another previous study reported elevated expression of the cis-SAGes BCL2L2-PABPN1 and CHFR-GOLGA3, predominantly localized in the nucleus, in bladder cancer [42]. This evidence concerns the gene GOLGA3 and urinary bladder carcinoma.